Novo Nordisk Aktie
59,12
EUR
-1,76
EUR
-2,89
%
59,42
EUR
-0,58
EUR
-0,97
%
Werbung
Novo Nordisk Aktie Analyse
13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
02.05.16 | Novo Nordisk overweight | Barclays Capital | |
29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.02.16 | Novo Nordisk overweight | Barclays Capital | |
04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
08.01.16 | Novo Nordisk overweight | Barclays Capital | |
07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
06.01.16 | Novo Nordisk overweight | Morgan Stanley | |
02.12.15 | Novo Nordisk overweight | Morgan Stanley | |
25.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
20.11.15 | Novo Nordisk buy | Citigroup Corp. | |
20.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
20.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
19.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
03.11.15 | Novo Nordisk buy | Citigroup Corp. | |
30.10.15 | Novo Nordisk overweight | Morgan Stanley | |
29.10.15 | Novo Nordisk buy | Citigroup Corp. | |
26.10.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.10.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
28.09.15 | Novo Nordisk buy | Citigroup Corp. | |
28.09.15 | Novo Nordisk overweight | Morgan Stanley | |
28.09.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.09.15 | Novo Nordisk buy | Goldman Sachs Group Inc. |
Werbung
Werbung